≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

No data available for the lab value distribution.
Number of people
62 (82.26% female)
People with ≥2 records
12.90%
Median duration from first to last measurement
1.11 years

Coding

Definition

OMOP Concept ID
36304315— open in OHDSI Athena.
Part of collection
Certolizumab Ab with 0 other OMOP concept — open in OHDSI Athena.

OMOP mapping QC

OMOP concept ID Test name Measurement unit (harmonized unit) N people N records Missing measurement value Harmonized value distribution
Test outcome
NA
N
A
AA
L
LL
H
HH
36304315 s-sertoab — (—) 47 54 100.00% Distribution not available
36304315 s-sertoab au/ml (au/ml) 16 19 5.26% Distribution not available

Cohort

Number of people
62 (82.26% female)

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

No data available for the duration from to last measurement distribution.

Statistics

People with ≥2 records
12.90%
Median number of measurements per person
1.0
Median duration from first to last measurement
1.11 years

Number of measurements over the years

No data available for the distribution of number of measurements over the years.

Number of measurements per person

Distribution of lab values

No data available for the lab value distribution.

Value range per person

No data available for the distribution of value range per person.